Statistics for Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease

Total visits

views
Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease 443

Total visits per month

views
August 2024 0
September 2024 0
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0

File Visits

views
Honig_2018_trial.pdf 1528
java.util.UUID:94f5507b-27c6-4fef-bc8c-68d8aefe5b53 109
java.util.UUID:bd1bdf47-a6f9-43ba-a966-5ad98188c457 11
java.util.UUID:4cf7c3a9-dd17-4c97-b987-2fc5609d7c9d 5
java.util.UUID:2f46d996-45b5-4f60-80a6-226adf47124c 1

Top country views

views
United States 235
Germany 95
United Kingdom 11
China 10
Sweden 10
Ukraine 6
Russia 4
Canada 3
Vietnam 2
United Arab Emirates 1
Czechia 1
Spain 1
Lebanon 1
Malaysia 1
Netherlands 1

Top city views

views
Wilmington 55
Kiez 50
Fairfield 35
Gunzenhausen 31
Ann Arbor 22
Houston 14
Nürnberg 9
Cambridge 8
Mountain View 8
Jacksonville 7
Stockholm 7
Dearborn 6
Kiev 6
Los Angeles 6
White Plains 6
Endingen 5
Lake Mary 4
Beijing 3
Shenzhen 3
Washington 3
Brooklyn 2
Dong Ket 2
Guangzhou 2
Kansas City 2
Moscow 2
Saint Petersburg 2
San Francisco 2
Toronto 2
Alexandria 1
Alkmaar 1
Bangor 1
Beirut 1
Dubai 1
Exeter 1
Fuzhou 1
Greenfield 1
Hanover 1
La Roda De Andalucía 1
Las Vegas 1
Ling 1
Malmö 1
Philadelphia 1
Scottsdale 1
Seremban 1
Slapanice 1
Svängsta 1
Tustin 1
Warrington 1